ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE)

PRESS RELEASE

published on 08/29/2025 at 08:00, 6 months 26 days ago

OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM
OSE Immunotherapeutics reaffirms strategic priorities with comprehensive Q&A document ahead of AGM. Company focuses on Tedopi® and Lusvertikimab programs for value creation

Strategic Priorities OSE Immunotherapeutics Lusvertikimab Shareholder Q&A Tedopi®
BRIEF

published on 08/25/2025 at 07:05, 6 months 30 days ago

OSE Immunotherapeutics : Nouvelle Gouvernance et Objectifs Stratégiques

Stratégie Gouvernance Actionnaires Biotechnologie Tedopi Et Lusvertikimab
BRIEF

published on 08/25/2025 at 07:05, 6 months 30 days ago

OSE Immunotherapeutics: New Governance and Strategic Objectives

Shareholders Biotechnology Governance Strategy Tedopi And Lusvertikimab
PRESS RELEASE

published on 08/25/2025 at 07:00, 6 months 30 days ago

OSE Immunotherapeutics Propose une Evolution de sa Gouvernance et Réaffirme ses Priorités Stratégiques à l’Approche de son Assemblée Générale Annuelle
OSE Immunotherapeutics propose une évolution de sa gouvernance et réaffirme ses priorités stratégiques. Assemblée Générale Annuelle le 30 septembre 2025 à Paris

Gouvernance Évolution Assemblée Générale Annuelle Priorités Stratégiques OSE Immunotherapeutics
PRESS RELEASE

published on 08/25/2025 at 07:00, 6 months 30 days ago

OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting
OSE Immunotherapeutics announces proposed governance evolution and reaffirms strategic priorities ahead of Annual General Meeting. Company focuses on Tedopi® and Lusvertikimab to unlock full potential

Strategic Priorities Governance Evolution OSE Immunotherapeutics Lusvertikimab Tedopi
BRIEF

published on 08/20/2025 at 18:05, 7 months 4 days ago

OSE Immunotherapeutics Appoints Thomas Gidoin as CFO

Chief Financial Officer Strategic Planning Biotech Financing OSE Immunotherapeutics Thomas Gidoin
BRIEF

published on 08/20/2025 at 18:05, 7 months 4 days ago

OSE Immunotherapeutics nomme Thomas Gidoin au poste de directeur financier

Directeur Financier Planification Stratégique OSE Immunotherapeutics Financement Des Biotechnologies Thomas Gidoin
PRESS RELEASE

published on 08/20/2025 at 18:00, 7 months 4 days ago

OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer
OSE Immunotherapeutics appoints Thomas Gidoin as Chief Financial Officer, bringing deep expertise in capital markets and financial strategy to the company. Gidoin succeeds Anne-Laure Autret-Cornet

Chief Financial Officer Capital Markets Financial Strategy OSE Immunotherapeutics Thomas Gidoin
PRESS RELEASE

published on 08/20/2025 at 18:00, 7 months 4 days ago

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier
Nomination de Thomas Gidoin comme nouveau Directeur Financier chez OSE Immunotherapeutics. Il apporte 15 ans d'expertise internationale en finance et gouvernance

Biotechnologie Finance Directeur Financier OSE Immunotherapeutics Thomas Gidoin
BRIEF

published on 07/02/2025 at 08:05, 8 months 22 days ago

Mises à jour d'OSE Immunotherapeutics sur les procédures judiciaires

Transparence Assemblée Des Actionnaires OSE Immunotherapeutics Procédures Judiciaires Tribunal De Commerce De Nantes

Published on 03/24/2026 at 23:42, 4 hours 20 minutes ago

Presentation to Gold Coast Gold Conference
Published on 03/24/2026 at 23:00, 5 hours 2 minutes ago

Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Published on 03/24/2026 at 18:55, 9 hours 7 minutes ago

Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 14 hours 32 minutes ago

GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 14 hours 32 minutes ago

Innodata Announces Date of Annual Shareholder Meeting

View all ACCESSWIRE

Published on 03/24/2026 at 21:08, 6 hours 54 minutes ago

Linedata Services: Linedata annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
Published on 03/24/2026 at 19:49, 8 hours 13 minutes ago

EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Published on 03/24/2026 at 19:41, 8 hours 20 minutes ago

ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 8 hours 57 minutes ago

WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 9 hours 22 minutes ago

EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026

View all EQS

Published on 03/24/2026 at 18:21, 9 hours 41 minutes ago

Résultats annuels 2025
Published on 03/24/2026 at 18:21, 9 hours 41 minutes ago

2025 Annual results
Published on 03/24/2026 at 18:00, 10 hours 2 minutes ago

i2S : Résultats annuels 2025
Published on 03/24/2026 at 17:46, 10 hours 16 minutes ago

NRJ GROUP - Avis résultats annuels 2025
Published on 03/24/2026 at 17:46, 10 hours 16 minutes ago

NRJ GROUP - Press release annual results 2025

View all LES ECHOS COMFI WIRE

News